| Drug Name: | Besifloxacin (141388-76-3) |
|---|---|
| PubChem ID: | 10178705 |
| SMILES: | C1CCN(C[C@@H](C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F |
| InchiKey: | QFFGVLORLPOAEC-SNVBAGLBSA-N |
| Therapeutic Category: | Antineoplastic Agents, Enzyme Inhibitors, Topoisomerase II Inhibitors, Topoisomerase Inhibitors |
| Molecular Weight (dalton) | : | 393.846 |
| LogP | : | 3.1447 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 88.56 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Conjunctival Hyperaemia | ADReCS |
| Eye Irritation | ADReCS |
| Eye Pain | ADReCS |
| Eye Pruritus | ADReCS |
| Headache | ADReCS |
| Vision Blurred | ADReCS |